Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN - 1 Mar 2023

Gheybi Kazzem, Jiang Jue, Mutambirwa Shingai B A, Soh Pamela X Y, Kote-Jarai Zsofia, Jaratlerdsiri Weerachai, Eeles Rosalind A, Bornman M S Riana, Hayes Vanessa M

Abstract excerpt

BACKGROUND: Germline testing for prostate cancer is on the increase, with clinical implications for risk assessment, treatment, and management. Regardless of family history, NCCN recommends germline testing for patients with metastatic, regional, very-high-risk localized, and high-risk localized prostate cancer. Although African ancestry is a significant risk factor for aggressive prostate cancer, due to a lack...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ Cells

Share to Germ-Line Mutation

Share to Prostate Cancer Diagnosis and Treatment

Share to Prostate Cancer Treatment and Research

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 36898365
DOI: 10.6004/jnccn.2022.7097

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer.PMID 36898365Read ↗

Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic TestingSemantic proximity Read ↗

Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry.Semantic proximity Read ↗

Prostate cancer genetic risk and associated aggressive disease in men of African ancestrySemantic proximity Read ↗

Prostate cancer genetic risk and associated aggressive disease in men of African ancestry.Semantic proximity Read ↗

Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African menSemantic proximity Read ↗

Rare germline mutations in African American men diagnosed with early‐onset prostate cancerSemantic proximity Read ↗

Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African menSemantic proximity Read ↗

Whole-Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naïve, High-Risk Prostate Cancer.Semantic proximity Read ↗

Integrating Pathogenic Variants, Polygenic Risk Score, and Family History for Prostate Cancer Risk Estimation in Men of African Ancestry.Semantic proximity Read ↗

African-specific molecular taxonomy of prostate cancer.Semantic proximity Read ↗

Precision medicine targets for prostate cancers in African American menSemantic proximity Read ↗

Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African AncestrySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.